Smoking Cessation and Menstrual Cycle Phase (NCT05515354)
Coordinating Smoking Cessation Treatment With Menstrual Cycle Phase to Improve Quit Outcomes: A Randomized Controlled Trial
🩺 Plain-English Summary (8th-Grade Level)
Tobacco use is a risk factor for at least 20 types of cancer and remains the leading preventable cause of cancer in Canada. Smoking cessation is an important cancer prevention strategy for the close to 2 million Canadian women who currently smoke. However, findings from controlled trials and real-world clinical settings indicate that women have greater difficulty achieving abstinence following a quit attempt than men. There is some evidence that hormonal levels and fluctuations throughout the menstrual cycle (MC) may contribute to the greater difficulty women experience when trying to quit smoking. In this study, the start of a quit attempt using nicotine replacement therapy (NRT) will be targeted to specific phases of MC. It was hypothesized that starting a quit attempt during the first half of MC (follicular phase) will result in increased quit success compared to starting during the second half of MC (luteal phase) or the usual practice of not targeting quit start date to MC phase.
Who can join: Review the eligibility criteria below.
Location: Centre for Addiction and Mental Health, Nicotine Dependence Clinic — Toronto, Ontario
Age range: 18 Years to 40 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Centre for Addiction and Mental Health, Nicotine Dependence Clinic — Toronto, Ontario
📞 Contact the Study Coordinator
Phone: (416) 535-8501
Email: laurie.zawertailo@camh.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Nicotine Dependence
- Targeting Orexin to Treat Nicotine Dependence — Belmont, Massachusetts
- Electronic Cigarettes and Reactivity to Smoking Cues — Belmont, Massachusetts
- Sex Differences in E-Cigarette Perception — New Haven, Connecticut
- NeuroControl of Nicotine Dependence — Columbia, Missouri
- Brain/Craving Response to Smoking Cues After Oral Nicotine Pouch Use — Los Angeles, California
- Orexin s Role in the Neurobiology of Substance Use Disorder — Baltimore, Maryland
Explore by condition: All Nicotine Dependence clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.